Exelixis Inc at Oppenheimer Healthcare Conference Transcript
So we're with Christopher Senner and Andrew Peters from Exelixis. Chris is Executive Vice President and Chief Financial Officer at Exelixis and joined the company in 2015.
Prior to joining, he was Vice President, Corporate Finance at Gilead. Before Gilead, he spent 18 years with Wyeth. And before that, he holds a Bachelor of Science in Finance from Bentley College.
And Andrew, he's Vice President of Strategy. He joined in 2018 from Deutsche Bank, where he covered small and mid-cap biotech for 2 years, and he began his career in business development in Amylin Pharmaceuticals. He has a Master of Science from Keck and -- Institute of Applied Life Sciences and has a Bachelor's in Arts in Science and Management from Claremont.
So with that, maybe I'll start off asking you about your business, and you've recently started your R&D efforts, and you built up your R&D operation. You emphasize that a lot. How do you view capital allocation going forward in the near-term future?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
